Find clinical trials for Heart Disease in Louisville, KY
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Louisville, KY, USA:
with placebo in reducing the risk of the clinical consequences of AKI (MAKE) at 90 days in adult participants with CKD who undergo non-emergent cardiac...
Phase 3
Louisville, Kentucky, United States and 191 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Louisville, Kentucky, United States and 56 other locations
open- label, single arm, multicenter clinical trial to evaluate the safety and effectiveness of the Cordella PA Sensor System in NYHA Class III Heart...
Louisville, Kentucky, United States and 74 other locations
This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions p...
Louisville, Kentucky, United States and 103 other locations
who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease. The trial tests...
Louisville, Kentucky, United States and 52 other locations
2.5) device during high-risk PCI in patients with reduced left-sided heart function will result in an improvement in symptoms, heart...
Louisville, Kentucky, United States and 133 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Louisville, Kentucky, United States and 588 other locations
cardiovascular events (MACE) including coronary heart disease (CHD) death, ischemic stroke, myocardial infarction (MI), acute limb...
Phase 3
Louisville, Kentucky, United States and 617 other locations
The research study is being done to see if ziltivekimab can be used to treat people who were admitted to hospital because of a heart attack. ...
Phase 3
Louisville, Kentucky, United States and 735 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Louisville, Kentucky, United States and 736 other locations
Clinical trials
Research sites
Resources
Legal